4//SEC Filing
Rivard Paul 4
Accession 0001493152-21-009302
CIK 0001321834other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 9:44 PM ET
Size
8.6 KB
Accession
0001493152-21-009302
Insider Transaction Report
Form 4
Rivard Paul
EVP of Operations, GC
Transactions
- Award
Stock Option (Right to Buy)
2021-04-16+77,180→ 77,180 total(indirect: See footnote)Exercise: $2.59Exp: 2023-04-16→ Common Stock (77,180 underlying) - Award
Stock Option (Right to Buy)
2021-04-16+77,180→ 77,180 totalExercise: $2.59Exp: 2023-04-16→ Common Stock (77,180 underlying)
Footnotes (4)
- [F1]Received in exchange for a stock option to acquire 200,000 shares of common stock of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") at $1.00 per share in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share.
- [F2]These options are fully vested and exercisable.
- [F3]Received in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share in connection with the Merger.
- [F4]These shares are jointly held by the reporting person and Jennifer Rivard as trustees for the Paul Rivard and Jennifer Rivard Revocable Living Trust.
Documents
Issuer
MyMD Pharmaceuticals, Inc.
CIK 0001321834
Entity typeother
Related Parties
1- filerCIK 0001857479
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 9:44 PM ET
- Size
- 8.6 KB